Recruitment - Articles

New on-line system for hospital pharmacies makes ordering medicines easier, quicker and, being paperless, virtually error-free.
The Agency has supported the development of the NHS Pharmaceutical Messaging Service, a pilot scheme which aims to streamline the supply of medicines to England’s hospitals. The project pinpointed efficiencies and is delivering savings through the introduction of an electronic ordering, information and invoicing system for hospital pharmacies. The Agency has supported the development of the NHS Pharmaceutical Messaging Service, a pilot scheme which aims to streamline the supply of medicines to England’s hospitals. The project pinpointed efficiencies and is delivering savings through the introduction of an electronic ordering, information and invoicing system for h…

Did you know you can generate SMS messages from any software that can send an email or generate an HTTP request such as Outlook, Lotus Notes..?
These practical, secure and easy-to-use products from PharmiWeb partner, RedOxygen, allow users to: Send SMS messages to staff, suppliers and customers around the world from their desktops using Microsoft Outlook, Lotus Notes or a delivery channel for a custom developed CRM/ERP application Receive message replies in their inboxes or on their mobile phones Receive calendar reminders on their phones via SMS Control corporate account usage, cost and technical support with online management tools. Several beneficial applications also help employees remain connected to both local and remote colleagues: Sales Managers can coordinate meetings with f…

The Healthcare Industry is currently experiencing the effects of a global shortage of qualified and experienced clinical research professionals – and this situation has evolved into the industry’s very own version of ‘Catch 22’. While employers are looking to hire candidates who are already experienced in the practice of clinical research, new Life Science graduates and others wishing to start on a career in the Healthcare Industry are unable to gain such experience without first being hired.
CRAcademyThe Healthcare Industry is currently experiencing the effects of a global shortage of qualified and experienced clinical research professionals – and this situation has evolved into the industry’s very own version of ‘Catch 22’. While employers are looking to hire candidates who are alread…

There’s a phrase being mentioned in pharmaceutical circles more and more. Sometimes with a puzzled air, other times delivered reverentially as the silver bullet that will resolve all ills: interim management.
There’s a phrase being mentioned in pharmaceutical circles more and more. Sometimes with a puzzled air, other times delivered reverentially as the silver bullet that will resolve all ills: interim management. The dictionary definition of an interim (an intervening time, provisional, temporary, etc) is easier to find than one for an interim manager, but the Interim Management Association is a good place to start. It defines interim management as: “The rapid provision of senior executives to manage change or transition commissioned on an assignment basis, who act for a third party in t…

Imagine the benefits of working for a global organisation which turns over over £4 billion per year worldwide but is primarily family owned and complete with family values? This is exactly what Merck offers.
Company in View The best of both worlds – A global Organisation with family values Imagine the benefits of working for a global organisation which turns over £4.5 billion per year worldwide but is primarily family owned and complete with family values?  This is exactly what Merck offers. Merck, (not to be confused with MSD) is a company with over 34,000 employees, working in 55 countries, producing a financial output which places it as a major player in the world wide market.  The future pipeline is impressive with new products to be launched in key growth areas of Oncology…

Bipolar affective disorder – previously referred to as manic depression – is a psychiatric disorder affecting at least 1% of the UK population, and depending on the definition used, may affect as many as 5% of the population. A recent World Health Organization analysis of the major global causes of disability, economic and social burden, indicated that bipolar affective disorders are ranked in the top ten, and account for 2.5% of total years lost to disability across all age groups.
Bipolar affective disorder – previously referred to as manic depression – is a psychiatric disorder affecting at least 1% of the UK population, and depending on the definition used, may affect as many as 5% of the population. A recent World Health Organization analysis of the major global causes of disability, e…

Dementia currently affects over 750,000 people in the UK, with 650,000 new cases arising each year across the European Union. Alzheimer’s disease is the major cause of dementia and accounts for about 55% of all cases. It is a progressive, degenerative disease which affects memory, judgement, orientation, behaviour and language skills, and can place an enormous stress on family caregivers, 49% of whom are over 70 years of age.
Dementia currently affects over 750,000 people in the UK, with 650,000 new cases arising each year across the European Union. Alzheimer’s disease is the major cause of dementia and accounts for about 55% of all cases. It is a progressive, degenerative disease which affects memory, judgement, orientation, behaviour and language skills, and can place an enormous stress…

A significant rise in sales of InterMune's hepatitis drug Infergen, from $9.3 million in 2003 to $22.3 million in 2004, is the result of the company's focus on marketing Infergen to HCV non-responders. In targeting this vital patient sub-group, InterMune could gain a useful head start in an area of hepatitis treatment that is set to become fiercely competitive in the years ahead.
Infection with the hepatitis C virus (HCV) is four times more common than HIV infection, and chronic HCV infection (CHC) is associated with considerable morbidity and mortality due to CHC-associated liver cirrhosis and cancer. Between 170-200 million individuals are estimated to be infected worldwide, with a prevalence of approximately 7.5 million in the seven major markets and 2.7 million in the alone, according…

Five million adult asthmatics may have predominantly neutrophilic inflammation. Whilst this phenotype is usually associated with severe asthma, it may be more prevalent across the range of disease severities than originally thought. The emergence of this phenotype in asthma raises important implications for treatment practice.
Severe asthma is a term that encompasses patients with a steroid-resistant, irreversible, refractory, brittle, near fatal and difficult-to-control or poorly controlled condition. Both genetic and environmental elements are likely to play an important role in the development of severe disease, although it is unclear what is the most important factor in its development. Although many asthmatics have been severely affected for most of their lives, there appears to be a…

For people with migraine, today’s world is a better world than the one their parents knew. The last 15 years have seen major advances, giving us not only a much clearer understanding of the disorder but also considerably more effective therapies. Treatments exist that – if made available and used in the right way – can substantially relieve the majority of people affected by migraine.
For people with migraine, today’s world is a better world than the one their parents knew. The last 15 years have seen major advances, giving us not only a much clearer understanding of the disorder but also considerably more effective therapies. Treatments exist that – if made available and used in the right way – can substantially relieve the majority of people affected by migraine. Availability and correct…

INC RESEARCH MOVES INTO NEW EUROPEAN HEADQUARTERS TO ACCOMMODATE CONTINUING GLOBAL EXPANSION
 

Epilepsy is a common condition in the UK, with an incidence of approximately 80 cases per 100,000 population per year, and a prevalence of 5–10 cases per 1000. Yet, despite this high prevalence, it remains a stigmatising condition, with occupational and social disadvantages imposed on the individual. Epilepsy is difficult to diagnose, requiring a detailed history, and is complex to manage.
Epilepsy is a common condition in the , with an incidence of approximately 80 cases per 100,000 population per year, and a prevalence of 5–10 cases per 1000. Yet, despite this high prevalence, it remains a stigmatising condition, with occupational and social disadvantages imposed on the individual. Epilepsy is difficult to diagnose, requiring a detailed history, and is complex to manage. The primary aim…

Morgan Levy (formally E-Focus Resourcing) has pleasure in announcing that we have re-branded to Morgan Levy with effect from January 2005.

The outlook for hepatocellular carcinoma (HCC) sufferers is bleak - current medication has a five-year survival rate for those with liver cancer of less than 5% in the developed world and even lower in developing countries. However, patients in trials of a new drug called Sorafenib have seen their survival times double. Datamonitor's Dr Lorna Fern investigates...
Liver cancer is currently the fifth most common cancer in the world, responsible for about one million cases and half a million deaths globally every year. HCC is a tumor of the liver that arises from focal scarring points in cirrhotic liver tissue, and its global incidence is on the increase, concurrent with a global increase in the number of cases of viral hepatitis and of alcoholic cirrhosis in developed countries. Some specia…

Britain’s hospital patients, led by Claire Rayner, today called for healthcare professionals to get behind the UK’s first ever Clean Hospitals Summit, planned for April 14-15, 2005.
Britain’s hospital patients, led by Claire Rayner, today called for healthcare professionals to get behind the UK’s first ever Clean Hospitals Summit, planned for April 14-15, 2005.Claire, a former senior Sister, and a recent sufferer of MRSA, said it was "essential" for good representation, or the public would wonder if the industry was concerned at all. The combined conference and exhibition in The Hilton London Metropole, will be run by the Patients Association, of which Claire is President. It will bring together delegates from all areas of the NHS, industry, and concerned public organisations. It aims t…

The recent announcement by the FDA's associate director for science and medicine that sales of GlaxoSmithKline's asthma drug Serevent should be restricted, or halted, led to an estimated 3.8% fall in the company's share price. However, Datamonitor's Laura Harris comments that, with Seretide accounting for the majority of GSK's asthma sales, the panic may be premature.
During a senate hearing, convened following the withdrawal of Merck & Co.'s COX-2 Vioxx (rofecoxib) in September, the FDA's David Graham commented that the safety profile of five other currently marketed drugs should be closely examined. Pfizer's COX-2 Bextra (valdecoxib), similar to Vioxx, was mentioned, as were Astra-Zeneca's cholesterol-lowering statin Crestor (rosuvastatin calcium), Roche's acne treatment Accutane (iso…

At a recent hearing into the Vioxx affair, the FDA's Dr David Graham named five drugs that he considers too dangerous to be on the market. However, in his testimony, Dr Graham also cited Sanofi-Aventis' Arava as a drug he has recommended be withdrawn. Unlike the other five drugs, Arava has largely escaped the media spotlight, but there may yet be some tough questions asked about its safety.
Arava (leflunomide) is marketed by Aventis, part of Sanofi-Aventis, and recorded sales of $288 million in 2003. It is an oral disease modifying treatment for rheumatoid arthritis (RA), and may be next in the firing line for increased regulatory scrutiny, in the wake of the withdrawal of Vioxx (rofecoxib). Dr Graham, the Associate Director for Science and Medicine in the FDA's Office of Drug Safety, cite…

Unique intelligence from eyeforpharma: 'Barriers, best practices and measuring ROI for patient compliance programmes'
Get your hands on this unique intelligence from eyeforpharma: This report will : Deliver first-hand insight into the present and future concerns for implementing successful patient compliance programs Identify the most pressing issues facing patient compliance teams across the industry Recommend potential solutions to overcome adherence barriers and to maximize compliance program ROI http://www.eyeforpharma.com/pceuro05/report/4 For more information contact Izzy Wakeling on iwakeling@eyeforpharma.com or +44(0) 20 73 75 8522

Influenza is a global disease which imposes a huge medical and economic burden inevery country of the world. The UK is no exception with one caveat - the virus is probably monitored and tracked more in the UK than any other country around the globe. Over the years, GPs have played a leading role in estimating the quantitative impact of influenza. This started with the pioneering work of William Pickles in the Wensleydale villages and continued with Edgar Hope-Simpson in Cirencester.
Influenza is a global disease which imposes a huge medical and economic burden inevery country of the world. The UK is no exception with one caveat - the virus is probably monitored and tracked more in the UK than any other country around the globe. Over the years, GPs have played a leading role in estimating th…

School can be a difficult place at the best of times, however for the 20 million plus children in the seven major pharmaceutical markets that suffer from attention deficit and hyperactivity disorder (ADHD), it can be especially troubling. This exacerbated by the fact that many patients aren't receiving the best available treatment, according to new research from Datamonitor.
The report suggests that many patients ADHD patients are adversely affected because physicians are sticking with older immediate release, short duration drugs rather than a number of newer long-acting therapies that are on the market. Hugely undiagnosed Datamonitor estimates that 23 million children and adolescents across the seven major pharmaceutical markets suffer from ADHD, a physician perceived prevalence rate o…